 clinic spectrum thrombocytosi thrombocythemia platelet product result order matur development hierarchi megakaryocyt progenitor cell varieti cytokin gm-csf stimulatori effect sever cytokin tgf-beta platelet glycoprotein platelet factor interferon inhibitori effect platelet product part autocrin control loop excess platelet product pseudothrombocytosi thrombocytosi thrombocythemia clinic featur criteria term thrombocytosi reactiv natur absenc arteri diseas prolong immobl littl risk regardless platelet number contrast thrombocythemia primari myeloprolif lesion signific thrombohemorrhag event natur histori rational approach reduct control clinic sequela clinic therapeut option new agent anagrelid